Epilepsy · Neurology · 6 drugs · 7 indications
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|---|---|---|---|---|
| Padsevonil | UCB | SV2A/GABAA modulator | Small molecule | PO | PHASE3 |
| STACCATO alprazolam | UCB | GABA-A receptor modulator (benzodiazepine) | Small molecule (inhaled) | Inhaled | PHASE3 |
| Briviact | UCB | SV2A ligand | Small molecule | PO | APPROVED |
| Keppra | UCB | SV2A ligand | Small molecule | Oral/IV | APPROVED |
| Vimpat | UCB | Sodium channel blocker (VGSC) | Small molecule | PO | APPROVED |
| Nayzilam | UCB | GABA-A receptor modulator (benzodiazepine) | Small molecule | Nasal | APPROVED |